France Newborn Screening Market Size & Outlook, 2025-2033
Related Markets
France newborn screening market highlights
- The France newborn screening market generated a revenue of USD 36.1 million in 2024 and is expected to reach USD 67.5 million by 2033.
- The France market is expected to grow at a CAGR of 7.3% from 2025 to 2033.
- In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2024.
- Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.
Newborn screening market data book summary
| Market revenue in 2024 | USD 36.1 million |
| Market revenue in 2033 | USD 67.5 million |
| Growth rate | 7.3% (CAGR from 2025 to 2033) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Electrophoresis |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
| Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Other key industry trends
- In terms of revenue, France accounted for 4.0% of the global newborn screening market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK newborn screening market is projected to lead the regional market in terms of revenue in 2033.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 50.8 million by 2033.
Tandem mass spectrometry was the largest segment with a revenue share of 26.59% in 2024. Horizon Databook has segmented the France newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2021 to 2033.
French government is actively involved in the screening of newborns for presence of any abnormalities. The national program conducts over 1 million tests annually on more than 0.8 million newborns. According to statistics, the mortality rate is about 3.37 in 1,000 babies accounting for 34% of the neonate population.
Recently, a new mode for cystic fibrosis screening was developed by France, which can also be implemented in other countries. The Association Francaise pour le Depistage et la Prevention des Handicaps de l’Enfant officially works on reporting and maintaining information regarding newborn screening working at the regional level.
Haute autorité de santé (HAS)/French National Authority for Health, in 2011, recommended the inclusion of medium-chain acly-CoA dehydrogenase (MCAD) testing for the population of France by utilizing tandem mass spectrometry. Other tests carried out for the region include cystic fibrosis, hyperplasia, congenital hypothyroidism, phenylketonuria, and sickle cell disease.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Covidien | View profile | 10001+ | Dublin, Dublin, Ireland, Europe | http://www.covidien.com |
| Natus Medical | View profile | 1001-5000 | San Carlos, California, United States, North America | http://www.natus.com |
| Agilent Technologies | View profile | 10001+ | Santa Clara, California, United States, North America | http://www.agilent.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Masimo Corp | View profile | 3796 | 52 Discovery, Irvine, CA, United States, 92618 | https://www.masimo.com |
| Waters Corp | View profile | 7900 | 34 Maple Street, Milford, MA, United States, 01757 | https://www.waters.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
France newborn screening market size, by technology, 2021-2033 (US$M)
France Newborn Screening Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
